A study in human cardiac stromal cells identified the mir-1183 as having significantly higher expression (>4-fold) in cells from arrhythmogenic cardiomyopathy patients compared to healthy controls in an initial screen [Rainer et al. DOI:10.1186/s12864-018-4876-6].